FDA Device Intelligence
HomeDRG International Inc › EPO (Erythropoietin) ELISA

EPO (Erythropoietin) ELISA

DRG International Inc · Model EIA-3646 · UDI-DI 00840239036469

GGT Prescription
10
510(k) clearances
3
Adverse events
5
Recalls
9
Facilities

Description

The EPO ELISA is intended for the quantitative determination of Erythropoietin (EPO) in human serum.

Recalls

DateFirmReason
2025-02-03Beckman Coulter, Inc.Affected lot (439363) exhibited a negative dose drop of -22% with native patient samples compared to alternate reagent lots. Patient samples tested with the affected lot may demons
2024-01-24Siemens Healthcare Diagnostics, Inc.Siemens Healthcare Diagnostics has confirmed an average negative bias of -35% compared to the 3rd World Health Organization (WHO) International Standard (NIBSC code: 11/170) that i
2024-01-24Siemens Healthcare Diagnostics, Inc.Siemens Healthcare Diagnostics has confirmed an average negative bias of -35% compared to the 3rd World Health Organization (WHO) International Standard (NIBSC code: 11/170) that i
2022-06-14R & D Systems, Inc.The Instructions for Use (IFU, Part Number 750095) provided with the affected lots by the firm contains an error associated with product s CE marking. The CE mark contained in the
2005-09-30Nichols Institute DiagnosticsSome units in Lot 30-500953 (Calibration Verifier 2) are mislabeled as Calibration Verifier 3. Some units of Lot 30-500953 (Calibration Verifier 3) are mislabeled as Calibration Ve

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.